|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002199,
umls-concept:C0008976,
umls-concept:C0022265,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0553723,
umls-concept:C0580822,
umls-concept:C1522673,
umls-concept:C1547300,
umls-concept:C1548760,
umls-concept:C1550594
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
2007-5-21
|
|
pubmed:abstractText |
To conduct a phase III trial of adjuvant 13-cis-retinoic acid (13cRA) plus interferon alfa (IFN-alpha) for preventing tumor recurrence and second primary tumors (SPTs) of skin squamous cell carcinoma (SCC) among patients with aggressive skin SCC.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:BrewsterAbenaa MAM,
pubmed-author:ClaymanGary LGL,
pubmed-author:CliffordJohn LJL,
pubmed-author:CollinsRobertR,
pubmed-author:LeeJ JackJJ,
pubmed-author:LippmanScott MSM,
pubmed-author:MeyersChristina ACA,
pubmed-author:ReyesMary Jo T NecesitoMJ,
pubmed-author:SabichiAnita LAL,
pubmed-author:StromSara SSS,
pubmed-author:ZhouXianX
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1974-8
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17513803-Adult,
pubmed-meshheading:17513803-Aged,
pubmed-meshheading:17513803-Aged, 80 and over,
pubmed-meshheading:17513803-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17513803-Carcinoma, Squamous Cell,
pubmed-meshheading:17513803-Chemotherapy, Adjuvant,
pubmed-meshheading:17513803-Female,
pubmed-meshheading:17513803-Humans,
pubmed-meshheading:17513803-Interferon-alpha,
pubmed-meshheading:17513803-Isotretinoin,
pubmed-meshheading:17513803-Male,
pubmed-meshheading:17513803-Middle Aged,
pubmed-meshheading:17513803-Neoplasm Recurrence, Local,
pubmed-meshheading:17513803-Neoplasms, Second Primary,
pubmed-meshheading:17513803-Prognosis,
pubmed-meshheading:17513803-Prospective Studies,
pubmed-meshheading:17513803-Recombinant Proteins,
pubmed-meshheading:17513803-Skin Neoplasms,
pubmed-meshheading:17513803-Survival Rate
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma.
|
|
pubmed:affiliation |
Department of Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77230-1439, USA.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Clinical Trial, Phase III,
Research Support, N.I.H., Extramural
|
